share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Mar 22 04:42
Summary by Futu AI
Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 8,000 Class A shares on 03/21/2024, as per the latest filing. The shares, valued at approximately $85,980.09, were originally acquired on the same date through options granted on 07/23/2018. The transaction is part of a pre-planned trading arrangement established on 03/01/2023. Over the past three months, Tina has sold a total of 24,000 shares, generating gross proceeds of $286,576.3.
Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 8,000 Class A shares on 03/21/2024, as per the latest filing. The shares, valued at approximately $85,980.09, were originally acquired on the same date through options granted on 07/23/2018. The transaction is part of a pre-planned trading arrangement established on 03/01/2023. Over the past three months, Tina has sold a total of 24,000 shares, generating gross proceeds of $286,576.3.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.